PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX
Portfolio Pulse from
Kahn Swick & Foti, LLC reminds investors of a class action lawsuit against Pacira BioSciences, Inc. (PCRX) with a lead plaintiff deadline of March 14, 2025. The lawsuit concerns securities purchased between August 2, 2023, and August 8, 2024.
March 05, 2025 | 2:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences faces a class action lawsuit with a lead plaintiff deadline of March 14, 2025, for securities purchased between August 2, 2023, and August 8, 2024.
The class action lawsuit against Pacira BioSciences is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for lead plaintiff applications is March 14, 2025, which may increase volatility as the date approaches.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100